Topical administration of cyclosporin A in a solid lipid nanoparticle formulation

Sung Tae Kim, Dong Jin Jang, Jong Hyo Kim, Joo Yeon Park, Ji Soo Lim, So Yeon Lee, Kyung-Mi Lee, Soo Jeong Lim, Chong Kook Kim

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Cyclosporin A (CsA)-loaded solid lipid nanoparticles (SLN) were developed for improved skin penetration. CsA-loaded SLN, prepared using a hot homogenization method, were nano-sized (about 73 nm) with a slightly negative surface charge (about -16 mV) and stable under physiological conditions regardless of CsA incorporation. In vitro permeation studies using murine skin mounted in the Franztype vertical diffusion assembly revealed that the skin permeation efficiency of CsA-loaded SLN was 2-fold higher than that of CsA-oil mixture in viable skin. Furthermore, topically administered CsAloaded SLN relieved symptoms of atopic dermatitis (AD) in an in vivo murine model of AD by decreasing the T helper (Th) 2 cell-related cytokines interleukin (IL)-4 and -5. These results suggest that SLN are effective drug carriers for topical delivery and that CsA-loaded SLN can be therapeutically applied in allergy-related skin disorders.

Original languageEnglish
Pages (from-to)510-514
Number of pages5
JournalPharmazie
Volume64
Issue number8
DOIs
Publication statusPublished - 2009 Aug 1

Fingerprint

Topical Administration
Nanoparticles
Cyclosporine
Lipids
Skin
Atopic Dermatitis
Th2 Cells
Drug Carriers
Interleukin-5
Interleukin-4
Hypersensitivity
Oils
Cytokines

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Kim, S. T., Jang, D. J., Kim, J. H., Park, J. Y., Lim, J. S., Lee, S. Y., ... Kim, C. K. (2009). Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. Pharmazie, 64(8), 510-514. https://doi.org/10.1691/ph.2009.8373

Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. / Kim, Sung Tae; Jang, Dong Jin; Kim, Jong Hyo; Park, Joo Yeon; Lim, Ji Soo; Lee, So Yeon; Lee, Kyung-Mi; Lim, Soo Jeong; Kim, Chong Kook.

In: Pharmazie, Vol. 64, No. 8, 01.08.2009, p. 510-514.

Research output: Contribution to journalArticle

Kim, ST, Jang, DJ, Kim, JH, Park, JY, Lim, JS, Lee, SY, Lee, K-M, Lim, SJ & Kim, CK 2009, 'Topical administration of cyclosporin A in a solid lipid nanoparticle formulation', Pharmazie, vol. 64, no. 8, pp. 510-514. https://doi.org/10.1691/ph.2009.8373
Kim ST, Jang DJ, Kim JH, Park JY, Lim JS, Lee SY et al. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. Pharmazie. 2009 Aug 1;64(8):510-514. https://doi.org/10.1691/ph.2009.8373
Kim, Sung Tae ; Jang, Dong Jin ; Kim, Jong Hyo ; Park, Joo Yeon ; Lim, Ji Soo ; Lee, So Yeon ; Lee, Kyung-Mi ; Lim, Soo Jeong ; Kim, Chong Kook. / Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. In: Pharmazie. 2009 ; Vol. 64, No. 8. pp. 510-514.
@article{697c7293a38c41f2a2be54c69a4d5b1b,
title = "Topical administration of cyclosporin A in a solid lipid nanoparticle formulation",
abstract = "Cyclosporin A (CsA)-loaded solid lipid nanoparticles (SLN) were developed for improved skin penetration. CsA-loaded SLN, prepared using a hot homogenization method, were nano-sized (about 73 nm) with a slightly negative surface charge (about -16 mV) and stable under physiological conditions regardless of CsA incorporation. In vitro permeation studies using murine skin mounted in the Franztype vertical diffusion assembly revealed that the skin permeation efficiency of CsA-loaded SLN was 2-fold higher than that of CsA-oil mixture in viable skin. Furthermore, topically administered CsAloaded SLN relieved symptoms of atopic dermatitis (AD) in an in vivo murine model of AD by decreasing the T helper (Th) 2 cell-related cytokines interleukin (IL)-4 and -5. These results suggest that SLN are effective drug carriers for topical delivery and that CsA-loaded SLN can be therapeutically applied in allergy-related skin disorders.",
author = "Kim, {Sung Tae} and Jang, {Dong Jin} and Kim, {Jong Hyo} and Park, {Joo Yeon} and Lim, {Ji Soo} and Lee, {So Yeon} and Kyung-Mi Lee and Lim, {Soo Jeong} and Kim, {Chong Kook}",
year = "2009",
month = "8",
day = "1",
doi = "10.1691/ph.2009.8373",
language = "English",
volume = "64",
pages = "510--514",
journal = "Die Pharmazie",
issn = "0031-7144",
publisher = "Govi-Verlag Pharmazeutischer Verlag GmbH",
number = "8",

}

TY - JOUR

T1 - Topical administration of cyclosporin A in a solid lipid nanoparticle formulation

AU - Kim, Sung Tae

AU - Jang, Dong Jin

AU - Kim, Jong Hyo

AU - Park, Joo Yeon

AU - Lim, Ji Soo

AU - Lee, So Yeon

AU - Lee, Kyung-Mi

AU - Lim, Soo Jeong

AU - Kim, Chong Kook

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Cyclosporin A (CsA)-loaded solid lipid nanoparticles (SLN) were developed for improved skin penetration. CsA-loaded SLN, prepared using a hot homogenization method, were nano-sized (about 73 nm) with a slightly negative surface charge (about -16 mV) and stable under physiological conditions regardless of CsA incorporation. In vitro permeation studies using murine skin mounted in the Franztype vertical diffusion assembly revealed that the skin permeation efficiency of CsA-loaded SLN was 2-fold higher than that of CsA-oil mixture in viable skin. Furthermore, topically administered CsAloaded SLN relieved symptoms of atopic dermatitis (AD) in an in vivo murine model of AD by decreasing the T helper (Th) 2 cell-related cytokines interleukin (IL)-4 and -5. These results suggest that SLN are effective drug carriers for topical delivery and that CsA-loaded SLN can be therapeutically applied in allergy-related skin disorders.

AB - Cyclosporin A (CsA)-loaded solid lipid nanoparticles (SLN) were developed for improved skin penetration. CsA-loaded SLN, prepared using a hot homogenization method, were nano-sized (about 73 nm) with a slightly negative surface charge (about -16 mV) and stable under physiological conditions regardless of CsA incorporation. In vitro permeation studies using murine skin mounted in the Franztype vertical diffusion assembly revealed that the skin permeation efficiency of CsA-loaded SLN was 2-fold higher than that of CsA-oil mixture in viable skin. Furthermore, topically administered CsAloaded SLN relieved symptoms of atopic dermatitis (AD) in an in vivo murine model of AD by decreasing the T helper (Th) 2 cell-related cytokines interleukin (IL)-4 and -5. These results suggest that SLN are effective drug carriers for topical delivery and that CsA-loaded SLN can be therapeutically applied in allergy-related skin disorders.

UR - http://www.scopus.com/inward/record.url?scp=70349761874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349761874&partnerID=8YFLogxK

U2 - 10.1691/ph.2009.8373

DO - 10.1691/ph.2009.8373

M3 - Article

C2 - 19746839

AN - SCOPUS:70349761874

VL - 64

SP - 510

EP - 514

JO - Die Pharmazie

JF - Die Pharmazie

SN - 0031-7144

IS - 8

ER -